Cytori Therapeutics Inc. | Mutual Funds
Mutual Funds that own Cytori Therapeutics Inc.
Vanguard Total Stock Market Index Fund
50,466
0.66%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
15,554
0.2%
1
0%
07/31/2018
Vanguard Extended Market Index Fund
9,597
0.13%
0
0%
07/31/2018
Vanguard Balanced Index Fund
2,337
0.03%
0
0%
07/31/2018
1,614
0.02%
0
0%
09/05/2018
Fidelity Spartan Total Market Index Fund
1,078
0.01%
1
0%
07/31/2018
AXA/Lord Abbett Micro Cap Portfolio
568
0.01%
0
0%
03/31/2018
iShares Core S&P Total US Stock Market ETF
472
0.01%
0
0%
09/06/2018
Vanguard Institutional Total Stock Market Index Fund
327
0%
0
0%
07/31/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
325
0%
0
0%
06/30/2018
| Address |
3020 Callan Road
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.cytori.com |
| Updated |
07/08/2019 |
| Cytori Therapeutics, Inc. is a late stage cell therapy company which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical trials. The company was founded by Ralph E. |
